Organogenesis Holdings Inc. Quarterly Interest Expense in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Organogenesis Holdings Inc. quarterly/annual Interest Expense history and growth rate from Q1 2017 to Q2 2024.
  • Organogenesis Holdings Inc. Interest Expense for the quarter ending June 30, 2024 was $620K, a 4.38% increase year-over-year.
  • Organogenesis Holdings Inc. Interest Expense for the twelve months ending June 30, 2024 was $2.08M, a 16.6% increase year-over-year.
  • Organogenesis Holdings Inc. annual Interest Expense for 2023 was $2.19M, a 9.01% increase from 2022.
  • Organogenesis Holdings Inc. annual Interest Expense for 2022 was $2.01M, a 72.2% decline from 2021.
  • Organogenesis Holdings Inc. annual Interest Expense for 2021 was $7.24M, a 35.8% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.08M $620K +$26K +4.38% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.06M $514K -$135K -20.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.19M $503K +$533K Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $1.66M $444K -$128K -22.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.79M $594K -$136K -18.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.92M $649K -$88K -11.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $2.01M -$30K -$883K -104% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $2.89M $572K -$910K -61.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $3.8M $730K -$1.7M -70% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $5.5M $737K -$1.73M -70.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $7.24M $853K -$2.04M -70.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $9.27M $1.48M -$1.49M -50.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $10.8M $2.43M -$481K -16.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $11.2M $2.47M -$40K -1.59% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $11.3M $2.89M +$284K +10.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $11M $2.97M +$542K +22.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $10.5M $2.91M +$725K +33.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $9.73M $2.51M +$732K +41.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $9M $2.6M -$59K -2.22% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $9.06M $2.43M -$513K -17.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $9.57M $2.19M -$594K -21.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $10.2M $1.78M -$651K -26.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $10.8M $2.66M +$380K +16.6% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-18
Q3 2018 $10.4M $2.94M +$707K +31.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $9.73M $2.78M +$750K +36.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $8.98M $2.43M +$837K +52.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $8.14M $2.28M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $2.23M Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 $2.03M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 $1.59M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.